BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• 

  Business

  Meet the Cancer Scientist Leading Genentech’s First Podcast

  October 25, 2016

   · 

  2 min read
• 

  Business

  Watch Out Juno and Kite Pharma: Novartis AG Clearly Not Done With CAR-T

  October 25, 2016

   · 

  2 min read
• On The 200th Anniversary Of Its Invention, The Stethoscope May Be On Its Last Lub-Dub

  October 25, 2016

   · 

  1 min read
• Genetown

  Ariad Could Follow Gilead’s — Or Mylan’s — Route In Drug Price Battle

  October 25, 2016

   · 

  1 min read
• Pharm Country

  EpiPen Shows A Path To Solve The Bigger Drug Pricing Challenge

  October 25, 2016

   · 

  1 min read
• Quark Life Sciences Fund Heavily Linked To Chinese Investors

  October 25, 2016

   · 

  1 min read
• 

  Drug Development

  Tiny Dipexium Craters After Lead Drug Locilex Flunks Phase III Trials

  October 25, 2016

   · 

  2 min read
• 

  Pharm Country

  Here Are 4 Biotech Stocks That Are Currently Undervalued

  October 25, 2016

   · 

  3 min read
• 

  Genetown

  Unnamed Fund Manager With Reliable Track Record Says High-Flying Corbus is About to Crash

  October 25, 2016

   · 

  3 min read
• Drug Development

  Why Aduro Biotech’s Clinical Hold Made Investors So Nervous

  October 25, 2016

   · 

  1 min read